Moderna has started dosing patients in a mid to late-stage study of its COVID 19 vaccine in children aged six months to less than 12 years. The study will evaluate the safety and effectiveness of two doses of its mRNA-1273 shot given 28 days apart and plans to enrol about 6,750 children in the UnitedContinue reading “Moderna Commences COVID Vaccine Trials In Children”
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
THE MONTHLY MOSQUITO 